| Mann, Wolfgang (Olympus before Advalytix AG before Alopex GmbH Managing Director) |
Managing Director |
BlueCatBio (BCB) (Group) |
Germany |
| Mannhardt, Boris (Biocom Projektmanagement GmbH 200710 Managing Director + Apanovis before IBG Sachsen-Anhalt + Bio-M) |
Managing Director |
Biocom (Group) |
Germany |
| Manninga, Heiko (Neuway Pharma GmbH 201504 Managing Director) |
Managing Director |
Neuway Pharma GmbH |
Germany |
| Manore, Hadar (Paragon Conventions 201304 Project Manager – Industry Liaison) |
Event Manager / Conference Manager |
Paragon (IL) (Group) |
Switzerland |
| Manth, Stefan M. (Mologen 201904– CEO prior Supervisory Board + SAB Member before Roche for 20 years |
Chief Executive Officer (CEO) |
Mologen (Group) |
Germany |
| Manthey, Jessica (Flanders (govt) 201704 Investment Promotion Manager at FIT in Berlin) |
Governmental Officer (personnel) |
Flanders (govt) |
Belgium |
| Manting, Erik (DCPrime 201807 CEO) |
Chief Executive Officer (CEO) |
Immunicum (Group) |
Netherlands |
| Manto, Michele (Galapagos 202001– promoted to CCO joined 201709 as SVP Commercial Operations before AbbVie |
Chief Commercial Officer (CCO) |
Galapagos (Group) |
Belgium |
| Manzello, John (Promosome 200810 CEO) |
Chief Executive Officer (CEO) |
Promosome LLC |
United States (USA) |
| Maraganore, John (Alnylam 200504 CEO) |
Chief Executive Officer (CEO) |
Alnylam (Group) |
United States (USA) |
| Marc-Kreucher, Frederic (Merck (DE) 201411 Technology Scouting Manager at Millipore SAS) |
Business Development Manager / Strategy Manager |
Merck (DE) (Group) |
United States (USA) |
| Marcell, Shawn M. (Metamark Genetics 201304– CEO before Hologic + Sequencom + SensíGen) |
Chief Executive Officer (CEO) |
Metamark Genetics Inc. |
United States (USA) |
| Marchfelder, Anita (Univ Ulm 201503 Professor) |
Professor |
University of Ulm |
Germany |
| Marchington, Tony (Avacta 201103 CEO of Oxford Medical Diagnostics) |
Chief Executive Officer (CEO) |
Avacta (Group) |
United Kingdom (GB) |
| Marcinowski, Stefan (BASF 201002 + 2008– VP Max Planck Society + 201002– Member BioÖkonomieRat) |
n. a. |
BASF (Group) |
Germany |
| Marcus, Katrin (Univ Bochum 201911 Prof + Director of Medical Proteome Center Bochum) |
Professor |
University of Bochum (Ruhr-Universität Bochum, RUB) |
Germany |
| Mardin, Balca (BioMed X 201611– Group Leader before EMBL) |
Researcher (industry) |
BioMed X GmbH |
Germany |
| Marengere, Luc (TVM 201308 Managing Partner) |
Managing Partner |
TVM (Group) |
Germany |
| Marett, Sean (BioNTech 202012 CBO + CCO 201506 COO before Evotec) |
Chief Operating Officer (COO) |
BioNTech (Group) |
Germany |
| Margeson, Kristen (Atlas Venture 201601 Director IR + Marketing) |
Public Relations Manager / Investor Relations Manager |
Atlas Venture (Group) |
United States (USA) |
| Margraf, Iris (Coral BioNet 201102 Director Business Development at Scil Technology GmbH) |
Business Development Manager / Strategy Manager |
Coral BioNet (Group) |
Germany |
| Marguerre, Wolfgang (Octapharma 201209 Chairman + Founder) |
Board member |
Octapharma (Group) |
Switzerland |
| Mariën, Rudi (Innogenetics 2007 Chairman + major owner) |
Venture Partner |
Biovest N.V. (Belgium, Rudi Mariën) |
Belgium |
| Marini, Davide (Firefly BioWorks 201310 CEO) |
Chief Executive Officer (CEO) |
Firefly BioWorks Inc. |
United States (USA) |
| Marino, Daniela (Cutiss 202006 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Cutiss AG |
Switzerland |
| Marinucci, Francesco (Partec 201212 Director of Partec Essential Healthcare division) |
President/Director/Head Business Group/Unit/Division |
Sysmex (Group) |
Germany |
| Mark, Antje (JeNaCell GmbH 201507 Marketing Manager) |
Sales Manager / Marketing Manager |
JeNaCell GmbH |
Germany |
| Mark, Daniel L. (SpinDiag GmbH 201707 Managing Director) |
Managing Director |
Spindiag GmbH |
Germany |
| Markfort, Rainer (Dentons 201501– Partner before Mayer Brown Düsseldorf + White & Case Berlin) |
Attorney / Lawyer |
Dentons (Group) |
Switzerland |
| Markovic, Sandra (LeadXPro 201804 Discovery Project Leader) |
Research & Development Manager |
LeadXPro AG |
Switzerland |
| Marks, Eric (BRAIN 201511–201610 COO before AB Enzymes 2006–2015 RESIGNED 10/16) |
Chief Operating Officer (COO) |
BRAIN (Group) |
Germany |
| Marlière, Philippe (Global Bioenergies 201702 Partner + Co-Founder) |
Company Founder |
Global Bioenergies (Group) |
France |
| Marriott, Peter (SGS 201012 Global Technical & Accreditation Manager) |
Technical Manager |
SGS (Group) |
Switzerland |
| Marron, Damian (Agalimmune 201603 CEO before TxCell + Cytheris + Trophos + NiCox + 3M + Orphan Europe) |
Chief Executive Officer (CEO) |
BioLineRx (Group) |
United Kingdom (GB) |
| Marsat, Jean-Luc (SGS 201611 Managing Director at SGS Clinical Research) |
Managing Director |
SGS (Group) |
Belgium |
| Marschner, Jens-Peter (Zelluna 201906– CMO before AbbVie + Affimed + Merck KGaA + Bayer + Boehringer Mannheim) |
Chief Medical Officer (CMO) |
Affimed (Group) |
Germany |
| Marseille, Oliver (Hemovent GmbH 201602 Managing Director (CTO) + Co-Founder) |
Managing Director |
Hemovent GmbH |
Germany |
| Marshak, Daniel R. (PerkinElmer 200807 CSO President China) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
PerkinElmer (Group) |
United States (USA) |
| Marshak, Daniel R. (Tecan 201710– Board proposed before PerkinElmer + Cambrex) |
Board member, non-executive |
Tecan (Group) |
Switzerland |
| Marshall, Alan G. (Florida State Univ 201003 Professor + National High Magnetic Field Labaoratory Director ICR Program) |
Professor |
Florida State University (FSU) |
United States (USA) |
| Martello, Wan Ling (Nestlé 201402 CFO) |
Chief Financial Officer (CFO) |
Nestlé (Group) |
Switzerland |
| Martens, Hubert (Salvia BioElectronics 202009 CEO + Founder) |
Chief Executive Officer (CEO) |
Salvia BioElectronics B.V. |
Netherlands |
| Martens, Lejon (A & M Labor für Analytik 201009 Head Mass Spec Lab) |
Head Mass Spectrometry / NMR Laboratory (industry) |
A&M Labor für Analytik (Group) |
Germany |
| Martens, Tom (UgenTec NV 201712 Managing Director) |
Managing Director |
UgenTec N.V. |
Belgium |
| Martin, Alex (Affectis 201003–CEO before CFO before Intercept before BioXell 200606 CFO before Novartis) |
Chief Executive Officer (CEO) |
Affectis Pharmaceuticals AG |
Germany |
| Martin, Chris (Auven Therapeutics 201506 CEO of ADC Therapeutics before CEO of Spirogen Ltd) |
Managing Director |
ADC Therapeutics (Group) |
Switzerland |
| Martin, Gilles G. (Eurofins 200701 CEO + founder) |
Chief Executive Officer (CEO) |
Eurofins (Group) |
France |
| Martin, Jacques-François (Parteurop Pharma 201602 President + Founder before Mymetics + Chiron Vaccines) |
Chief Executive Officer (CEO) |
Parteurop Pharma (FR) |
France |
| Martin, Javier (Genycell Biotech 201107 CEO) |
Chief Executive Officer (CEO) |
Genycell Biotech España S.L. |
Spain (España) |
| Martin, Keith (Apitope 201810 Non-Executive Director before 2006–201810 CEO RETIRED 10/18) |
Board member, non-executive |
Apitope (Group) |
United Kingdom (GB) |
| Martin, Kelly (Malin Corp 201508– CEO before Elan CEO) |
Chief Executive Officer (CEO) |
Élan (Group) |
Ireland, Republic of |
| Martin, Klaus (Topas Therapeutics 202008– CEO before Apobiologix + Polpharma Biologics + Sandoz Biopharmaceuticals) |
Chief Executive Officer (CEO) |
Topas Therapeutics GmbH |
Germany |
| Martin, Kurt (Hepacult 201104 Managing Director) |
Managing Director |
Hepacult GmbH |
Germany |
| Martin, Roland (Univ Zürich 201104– Professor + Head Dept Neuroimmunology at Univ Hospital Zürich before inims Hamburg) |
Professor |
University of Zurich (UZH) |
Switzerland |
| Martin-Garcia, Jesús (Eclosion 201207 General Partner + Founder + GeNeuro 201512 CEO) |
General Partner (venture partner) |
Eclosion S.A. |
Switzerland |
| Martínez, Héctor (Cellink 201908 CTO + Co-Founder) |
Chief Technology/Technical Officer (CTO) |
Cellink (Group) |
Sweden |
| Martinez, Ignacio (Flagship Pioneering 201303– General Partner formerly Syngenta Ventures) |
Investment Manager |
Flagship Pioneering |
United States (USA) |
| Martinez-Davis, Maya (GSK 202001– President of GSK US Pharma joined 9/19 before Merck (DE) + Pfizer) |
President/Director/Head Business Group/Unit/Division |
GlaxoSmithKline (GSK) (Group) |
United Kingdom (GB) |
| Martins, Fabien (MFPL 201107 Managing Director) |
Managing Director |
Max F. Perutz Laboratories GmbH (MFPL) |
Austria |
| Martyr, David (Tecan 201202–201903 announced CEO for 10/12 before Leica Microsystems RETIRED 4/19) |
Chief Executive Officer (CEO) |
Tecan (Group) |
Switzerland |
| Maruyama, Hisashi (Hitachi 201901 CEO of Hitachi Chemical Co. Ltd.) |
Chief Executive Officer (CEO) |
Showa Denko (SDK) (Group) |
Japan |
| Marx, Uwe (TissUse GmbH 201002– Managing Director + TU Berlin 201004– before ProBioGen –200411 CSO) |
Chief Executive Officer (CEO) |
TissUse GmbH |
|
| Maschek, Uwe (MagForce 200705–200912 CEO resigned 12/09 before Cephalon GmbH 1997–2007 Managing Director) |
Chief Executive Officer (CEO) |
MagForce (Group) |
Germany |
| Mascher, Hermann (pharm-analyt 201202 CEO + founder) |
Chief Executive Officer (CEO) |
pharm-analyt Labor GmbH |
Austria |
| Maskos, Michael (Institut für Mikrotechnik Mainz GmbH 201109– Managing Director) |
Managing Director |
Fraunhofer (Group) |
Germany |
| Mason, Christopher E. (Cornell Univ 201606 Assoc Prof Institute for Computational Biomedicine at Weill Cornell Medicine) |
Professor |
Cornell University |
United States (USA) |
| Mason, Mike (Eli Lilly 202001– President of Lilly Diabets before SVP Lilly Connected Care + Insulins) |
President/Director/Head Business Group/Unit/Division |
Eli Lilly (Group) |
United States (USA) |
| Mason, Richard (JnJ 201511– Head Innovation Centre London before XO1 + BTG + 4-Antibody + Advent Venture Partners + CAT) |
President/Director/Head Business Group/Unit/Division |
Johnson & Johnson (JnJ) (Group) |
United Kingdom (GB) |
| Mason, William T. (Bill) (The Sage Group 201503 Head of Sage Europe) |
Consultant (economic/technology) |
Sage Group (Group) |
United Kingdom (GB) |
| Massey, Ian (Synosis 200701– CEO before Roche Bioscience) |
Chief Executive Officer (CEO) |
Acorda Therapeutics (Group) |
United States (USA) |
| Massouras, Andreas (Saphetor SA 201604 CEO + Founder before Citigroup + Credit Suisse + Salomon Brothers) |
Chief Executive Officer (CEO) |
Saphetor S.A. (VarSome) |
Switzerland |
| Massuyeau, Laurent (Addex 200804–200909 Head Business Developm before Idenix RESIGNED 9/09 at Addex) |
Business Development Manager / Strategy Manager |
Addex (Group) |
Switzerland |
| Matentzoglu, Konstantin (Celonic 201711 CEO before Trenzyme GmbH 201202 Managing Director) |
Managing Director |
Celonic (Group) |
Switzerland |
| Mateus, Manel (Optimum Strategic Communications 201902) |
Public Relations Manager / Investor Relations Manager |
Optimum Strategic Communications |
United Kingdom (GB) |
| Mather, Simon (WestLB 200809 Analyst) |
Analyst (Financial / Industry) |
Portigon (Group) |
Germany |
| Mathers, Edward T. (Ed) (New Enterprise Associates 200808– before MedImmune) |
Partner (venture partner) |
New Enterprise Associates (NEA) |
United States (USA) |
| Mathew, Prasad (Bayer 201207 VP Global Medical Affairs Hematology at Bayer HealthCare) |
n. a. |
Bayer (Group) |
Germany |
| Mathias, Frank (Rentschler 201604– CEO before Medigene + Amgen GmbH + Servier DE + Hoechst) |
Managing Director |
Rentschler (Group) |
Germany |
| Mathis, Luc (Global Bioenergies 201710– CBO before CEO of Calyxt + Cellectis Plant Sciences) |
Chief Business Officer (CBO) |
Global Bioenergies (Group) |
France |
| Mathisen, Svein (BioInvent 200510 CEO) |
Chief Executive Officer (CEO) |
BioInvent International AB (OMXS: BINV) |
Sweden |
| Matillon, Valentin (Sophia Genetics 201801– CFO before Hobart Group + SITA + Electronic Arts + Hewlett-Packard Europe) |
Chief Financial Officer (CFO) |
Sophia Genetics (Group) |
Switzerland |
| Matis, Louis A. (Pieris 201508– Chief Development Officer before Alexion + CGI Pharmaceuticals) |
Chief Medical Officer (CMO) |
Pieris (Group) |
United States (USA) |
| Matlow, Stuart (Stu) (Thermo Fisher 201206 Public Relations Manager Chromatography + Mass Spectrometry before Agilent) |
Public Relations Manager / Investor Relations Manager |
Thermo Fisher (Group) |
United States (USA) |
| Matsumoto, Hiroshi (RIKEN 201910 President) |
President/Director/Head Business Group/Unit/Division |
RIKEN Research Cluster for Innovation (JP) |
Japan |
| Mattacchione, Anthony L. (Tony) (Albany Molecular 201804– before Bruker Corp CFO + EMD Millipore) |
Chief Financial Officer (CFO) |
Albany Molecular (AMRI) (Group) |
United States (USA) |
| Mattaj, Iain (EMBL 200811 Director General) |
President/Director/Head Business Group/Unit/Division |
EMBL (European Molecular Biology Laboratory) |
Germany |
| Matter, Alex (Singapore (govt) 201310 CEO ETC of A*STAR before Novartis Global Head Oncology Research) |
Chief Executive Officer (CEO) |
Singapore (govt) |
Singapore |
| Mattessich, Antony (Purdue Pharma 201612 Managing Director of Mundipharma International Ltd) |
Managing Director |
Purdue Pharma (Group) |
United Kingdom (GB) |
| Matthes, Thomas (Sloning 200705– CBO before Sigma-Aldrich SAFC Biosciences before CellSystems Biotechnologie GmbH) |
Chief Business Officer (CBO) |
MorphoSys (Group) |
Germany |
| Matthews, Werner |
n. a. |
Sparkassen-Finanzgruppe (DE) [FICTIVE UNIT, NOT OFFICIAL GROUP!] (Group) |
Germany |
| Matthyssens, Gaston (Vesalius Biocapital 201006 Investment Manager) |
Managing Partner (investment firm) |
Vesalius Biocapital (Group) |
Luxembourg |
| Mattil, Evi (Cryo-Save 201302– Chief Commercial Officer before Amoena + IMS Health (DE) + Chiron Vaccines) |
Chief Commercial Officer (CCO) |
Cryo-Save AG (CH) |
Switzerland |
| Mattingly, Quincy |
Business Development Manager / Strategy Manager |
Elchrom Scientific AG |
Switzerland |
| Mattner, Frank (Affiris 201502– Supervisory Board Member before CSO + Co-founder) |
Supervisory Board Member |
Affiris GmbH |
Austria |
| Matuschek, Elke (Kompass PR 201204) |
Public Relations Manager / Investor Relations Manager |
Kompass PR Elke Matuschek |
Germany |
| Matushansky, Igor (Hookipa Biotech 201802 CMO) |
Chief Medical Officer (CMO) |
Hookipa (Group) |
Austria |
| Matyas, Viktor (Aignostics 202008 CEO) |
Chief Executive Officer (CEO) |
Aignostics GmbH |
Germany |
| Matysiak, Stefan (febit 200705 VP + General Manager) |
General Manager (management) |
Hummingbird Diagnostics GmbH |
Germany |
| Matzen, Thomas J. C. |
n. a. |
BioAgency AG |
Germany |
| Matzke, Alexandra (Amcure GmbH 201202– Managing Director + Co-founder) |
Managing Director |
Amcure GmbH |
Germany |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo-2019.png){kind=logo}
1 2 3 ... 40 41 42 ... 73 74 75 
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
